Trial · NCT00536263
Adverse events132
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 132
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ASTHENIA | General disorders | PEG 1.0 mcg/kg QW x24 Weeks | 12 | 225 | 15 |
| other | ASTHENIA | General disorders | PEG 1.5 mcg/kg QW x24 Weeks | 25 | 221 | 40 |
| other | ASTHENIA | General disorders | PEG 1.5 mcg/kg QW x48 Weeks | 15 | 224 | 21 |
| other | FATIGUE | General disorders | PEG 1.0 mcg/kg QW x24 Weeks | 35 | 225 | 106 |
| other | FATIGUE | General disorders | PEG 1.5 mcg/kg QW x24 Weeks | 29 | 221 | 119 |
| other | FATIGUE | General disorders | PEG 1.5 mcg/kg QW x48 Weeks | 42 | 224 | 153 |
| other | PYREXIA | General disorders | PEG 1.0 mcg/kg QW x24 Weeks | 156 | 225 | 253 |
| other | PYREXIA | General disorders | PEG 1.5 mcg/kg QW x24 Weeks | 158 | 221 | 316 |
| other | PYREXIA | General disorders | PEG 1.5 mcg/kg QW x48 Weeks | 168 | 224 | 444 |
| other | WEIGHT DECREASED | Investigations | PEG 1.0 mcg/kg QW x24 Weeks | 5 | 225 | 5 |
| other | WEIGHT DECREASED | Investigations | PEG 1.5 mcg/kg QW x24 Weeks | 3 | 221 | 3 |
| other | WEIGHT DECREASED | Investigations | PEG 1.5 mcg/kg QW x48 Weeks | 16 | 224 | 19 |
| other | DECREASED APPETITE | Metabolism and nutrition disorders | PEG 1.0 mcg/kg QW x24 Weeks | 8 | 225 | 9 |
| other | DECREASED APPETITE | Metabolism and nutrition disorders | PEG 1.5 mcg/kg QW x24 Weeks | 16 | 221 | 22 |
| other | DECREASED APPETITE | Metabolism and nutrition disorders | PEG 1.5 mcg/kg QW x48 Weeks | 17 | 224 | 38 |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | PEG 1.0 mcg/kg QW x24 Weeks | 18 | 225 | 38 |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | PEG 1.5 mcg/kg QW x24 Weeks | 14 | 221 | 32 |
| other | ARTHRALGIA | Musculoskeletal and connective tissue disorders | PEG 1.5 mcg/kg QW x48 Weeks | 12 | 224 | 53 |
| other | MYALGIA | Musculoskeletal and connective tissue disorders | PEG 1.0 mcg/kg QW x24 Weeks | 54 | 225 | 108 |
| other | MYALGIA | Musculoskeletal and connective tissue disorders | PEG 1.5 mcg/kg QW x24 Weeks | 70 | 221 | 137 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00536263/events